BY Nadia Ntiamoah
Ghana has taken a decisive step to confront the long-standing public health burden posed by sickle cell disease with the launch of the National Sickle Cell Disease Screening and Case Management Guidelines, a policy move aimed at improving prevention, early diagnosis and long-term care nationwide.
The initiative comes against a troubling background in which sickle cell disease, one of the country’s most common inherited blood disorders, continues to claim lives and reduce quality of life due largely to late diagnosis and inconsistent care. Health experts estimate that about two per cent of all newborns in Ghana are affected by the condition—translating into roughly 18,000 children born with sickle cell disease each year.
In many cases, diagnosis only occurs after a child presents with severe pain crises or life-threatening complications, outcomes health authorities say are largely preventable with early screening and coordinated care.
Developed through extensive public consultations and collaboration among key stakeholders, the newly launched Guidelines establish, for the first time, a unified national framework for managing sickle cell disease across the health system.
The document outlines clear standards for screening, diagnosis, treatment, referral and long-term follow-up, ensuring that care for patients is no longer fragmented or dependent on location or facility level.
Speaking at the official launch, the Deputy Minister for Health, Dr. Grace Ayensu-Danquah, described the Guidelines as a major milestone in Ghana’s broader response to non-communicable diseases.
She noted that sickle cell disease has for decades been under-addressed despite its significant contribution to childhood illness and mortality, emphasizing that early detection remains the most effective tool for preventing avoidable complications.
According to the Deputy Minister, the Guidelines were developed in line with the Non-Communicable Disease Policy and Strategy adopted in 2022 and the Sickle Cell Disease Strategy covering the period 2024 to 2028.
These policy frameworks recognize sickle cell disease as a national priority and seek to integrate its management into routine healthcare delivery at all levels, from community-based services to tertiary hospitals.
Beyond clinical care, the Guidelines also promote public education, research and preventive interventions as central pillars of the sickle cell response.
Health authorities believe that increased awareness, coupled with standardized care pathways, will significantly reduce preventable deaths and improve the quality of life for people living with the condition.
Ayensu-Danquah commended the technical experts, health professionals and development partners who contributed to the development of the Guidelines, describing the collaborative process as critical to their success.
She further called on healthcare workers, policymakers, civil society organisations and international partners to commit to full implementation of the document, stressing that its impact will depend on collective action.
